| 1 |
34854060 | Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates. | 2022 Apr |
1 |
| 2 |
34827256 | In-Vitro Selection of Ceftazidime/Avibactam Resistance in OXA-48-Like-Expressing Klebsiella pneumoniae: In-Vitro and In-Vivo Fitness, Genetic Basis and Activities of β-Lactam Plus Novel β-Lactamase Inhibitor or β-Lactam Enhancer Combinations. | 2021 Oct 29 |
3 |
| 3 |
31424008 | Will ceftazidime/avibactam plus aztreonam be effective for NDM and OXA-48-Like producing organisms: Lessons learnt from In vitro study. | 2019 Jan-Mar |
2 |
| 4 |
28637339 | Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate. | 2017 Sep 1 |
1 |
| 5 |
28961715 | Effects of different resistance mechanisms on susceptibility to different classes of antibiotics in Klebsiella pneumoniae strains: a strategic system for the screening and activity testing of new antibiotics. | 2017 Dec 1 |
1 |
| 6 |
24379200 | Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model. | 2014 |
5 |
| 7 |
22041508 | In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae. | 2012 Jan |
1 |
| 8 |
22330912 | Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48. | 2012 May |
1 |